<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Beclomethasone - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Beclomethasone</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Respiratory / Allergy</div>
      <h1>Beclomethasone</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Beclomethasone 50mcg Nasal Inhaler</li>
          <li>Beclomethasone 50mcg Oral Inhaler (QVAR)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Beclomethasone 50mcg Nasal Inhaler (for allergic rhinitis)</strong></p>
        <ul>
          <li><strong>Allergic rhinitis (seasonal or perennial)</strong>
            <ul>
              <li>1–2 sprays (50–100 mcg) per nostril twice daily</li>
              <li>Maximum: 400 mcg/day (8 sprays total per day)</li>
              <li>Once symptoms controlled, may reduce to lowest effective dose (often 1 spray per nostril once or twice daily)</li>
            </ul>
          </li>
        </ul>
        <p><strong>Beclomethasone 50mcg Oral Inhaler (QVAR; for asthma)</strong></p>
        <ul>
          <li><strong>Asthma (maintenance therapy; not for acute relief)</strong>
            <ul>
              <li>Initial: 1–2 puffs (50–100 mcg) twice daily</li>
              <li>Moderate asthma: may increase to 2–4 puffs (100–200 mcg) twice daily</li>
              <li>Maximum: typically up to 400 mcg/day (follow prescriber guidance and product monograph for specific formulation)</li>
              <li>Titrate to lowest effective dose once asthma is controlled</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li><strong>Nasal inhaler:</strong> Symptomatic relief of seasonal and perennial allergic rhinitis</li>
          <li><strong>Oral inhaler (QVAR):</strong> Maintenance treatment of asthma as prophylactic therapy; not for acute bronchospasm or status asthmaticus</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to beclomethasone or formulation components</li>
          <li><strong>Nasal:</strong> Untreated localized infection involving nasal mucosa; recent nasal surgery or trauma (delayed healing risk)</li>
          <li><strong>Oral inhaler:</strong> Primary treatment of status asthmaticus or acute asthma episodes requiring intensive measures; not a rescue inhaler</li>
          <li>Active or quiescent tuberculosis (respiratory tract); untreated fungal, bacterial, or viral respiratory infections</li>
          <li>Systemic corticosteroid effects: prolonged high-dose use may cause adrenal suppression, growth suppression (children), osteoporosis, glaucoma, cataracts</li>
          <li>Oral candidiasis risk with oral inhaler (rinse mouth after use)</li>
          <li>Immunosuppression: caution with exposure to infections (e.g., chickenpox, measles) especially in non-immune individuals</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li><strong>Nasal inhaler:</strong> Nasal irritation, epistaxis (nosebleeds), sneezing, nasal dryness, unpleasant taste/smell, headache</li>
          <li><strong>Oral inhaler:</strong> Oral candidiasis (thrush), hoarseness, throat irritation, cough, headache</li>
          <li>Rarely: hypersensitivity reactions (rash, angioedema, bronchospasm)</li>
          <li>With prolonged high-dose use: systemic corticosteroid effects (adrenal suppression, osteoporosis, growth effects, hyperglycemia)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <p><strong>Nasal inhaler:</strong></p>
        <ul>
          <li>Shake well before each use</li>
          <li>Prime pump if new or not used for several days (follow product instructions)</li>
          <li>Clear nasal passages (blow nose gently) before use</li>
          <li>Insert nozzle into nostril, aim slightly away from nasal septum, and spray while inhaling gently through nose</li>
          <li>Rinse nozzle tip with water after use and dry; do not share between individuals</li>
        </ul>
        <p><strong>Oral inhaler (QVAR):</strong></p>
        <ul>
          <li>Shake well before each use</li>
          <li>Prime inhaler if new or not used for several days (follow product instructions)</li>
          <li>Exhale fully, then place mouthpiece in mouth and close lips around it</li>
          <li>Press canister and inhale slowly and deeply; hold breath for ~10 seconds</li>
          <li>Rinse mouth with water and spit out after use to reduce oral candidiasis risk</li>
          <li>Clean mouthpiece regularly as per product instructions</li>
          <li>Counsel: This is a preventive medication, not a rescue inhaler; continue even when feeling well</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li><strong>Nasal:</strong> Symptom control (rhinorrhea, sneezing, nasal congestion); nasal mucosa for irritation or epistaxis</li>
          <li><strong>Oral inhaler:</strong> Asthma control (symptom frequency, rescue inhaler use, peak flow if available); monitor for oral candidiasis (inspect mouth/throat periodically)</li>
          <li>Ensure proper inhaler technique (review periodically to ensure effectiveness)</li>
          <li>Monitor for systemic effects with prolonged high-dose use (growth in children, bone health, glucose control, adrenal function when clinically indicated)</li>
          <li>If no improvement within 2–4 weeks, reassess diagnosis, compliance, technique, and consider dose adjustment or alternate therapy</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Ensure crew understands difference between maintenance inhaler (beclomethasone) and rescue inhaler (e.g., salbutamol); do not substitute</li>
          <li>Review proper inhaler technique; improper use is common and reduces effectiveness</li>
          <li>For asthma: ensure rescue inhaler is also available; if increasing rescue use or worsening symptoms, escalate care</li>
          <li>Document asthma action plan if available; consider evacuation for severe or uncontrolled asthma</li>
          <li>Storage: protect from extreme heat; inhalers may malfunction or lose potency if exposed to high temperatures</li>
          <li>If crew develops oral thrush, treat appropriately and reinforce mouth rinsing after inhaler use</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (QVAR beclomethasone oral inhaler): <a href="https://pdf.hres.ca/dpd_pm/00055931.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00055931.PDF</a></li>
          <li>Health Canada product monograph (beclomethasone nasal spray): <a href="https://pdf.hres.ca/dpd_pm/00064171.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00064171.PDF</a></li>
          <li>Asthma Canada – Inhaler technique videos: <a href="https://asthma.ca/get-help/asthma-education/inhalers-devices/" target="_blank" rel="noopener">https://asthma.ca/get-help/asthma-education/inhalers-devices/</a></li>
          <li>Canadian Thoracic Society – Asthma guidelines: <a href="https://cts-sct.ca/guideline-library/" target="_blank" rel="noopener">https://cts-sct.ca/guideline-library/</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
